Hedge Fund News: Jim Chanos, Thomas Steyer & Carl Icahn

Short-seller James Chanos said he’s betting against shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) -2.92% amid its unsolicited $46 billion bid for Allergan, Inc.

Keep Reading →